Flebo.in recorded 2X rise in scale in FY23, losses widen
Gurugram-based Flebo.in, specializing in home blood collection, saw a 2.3X revenue increase to Rs 3.4 crore in FY23. However, expenses surged nearly seven-fold to Rs 17.9 crore, driven by advertising, employee benefits, and legal charges. The startup, founded by Ajay and Avani Singh, incurred losses of Rs 10.7 crore, a significant rise from FY22&
#039;s Rs 80 lakhs. Despite the financial challenges, Flebo.in&
#039;s ROCE improved to 184.00%.
#thekredible #Healthcare #HealthTech #Startup #MedicalTesting #FinancialPerformance #HealthServices #BusinessGrowth #StartupIndia #FleboIn #HealthcareIndustry #HomeBloodCollection
https://thekredible.com/blogs/flebo-in-recorded-2x-rise-in-scale-in-fy23-losses-widen
